Furin, a potential therapeutic target for COVID-19

Submit Time: 2020-02-23

Author: Hua Li 1,2 ; Canrong Wu 1 ; Yueying Yang 2 ; Yang Liu 2 ; Peng Zhang 2 ; Yali Wang 2 ; Qiqi Wang 2 ; Yang Xu 2 ; Mingxue Li 2 ; Mengzhu Zheng 1 ; Lixia Chen 2 ;

Institute: 1. Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China; 2.Wuya College of Innovation, Key Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China;

Abstracts

[英文摘要]A novel coronavirus (SARS-CoV-2) infectious disease has broken out in Wuhan, Hubei Province since December 2019, and spread rapidly from Wuhan to other areas, which has been listed as an international concerning public health emergency. We compared the Spike proteins from four sources, SARS-CoV-2, SARS-CoV, MERS-CoV and Bat-CoVRaTG13, and found that the SARS-CoV-2 virus sequence had redundant PRRA sequences. Through a series of analyses, we propose the reason why SARS-CoV-2is more infectious than other coronaviruses. And through structure based virtual ligand screening, we foundpotentialfurin inhibitors, which might be used in the treatment of new coronary pneumonia. " "

Download

Comment Hits:198287 Downloads:26874

From: 李华

Subject: Medicine, Pharmacy >> Pharmacology

DOI：10.12074/202002.00062

Keywords: SARS-CoV-2; Spike proteins; Furin; Inhibitors; Virtual screening;

Cite as: chinaXiv:202002.00062 (or this versionchinaXiv:202002.00062V1)

Recommended references： Hua Li,Canrong Wu,Yueying Yang,Yang Liu,Peng Zhang,Yali Wang,Qiqi Wang,Yang Xu,Mingxue Li,Mengzhu Zheng,Lixia Chen.(2020).Furin, a potential therapeutic target for COVID-19.[ChinaXiv:202002.00062] (Click&Copy)

Version History
[V1]	2020-02-23 16:55:52	chinaXiv:202002.00062V1	Download

Related Paper

1. 基于系统动力学理念的基本医疗保险门诊按人头付费政策对医疗费用的影响机制：以浙江省嵊州市门诊支付方式改革为例 2023-05-31

2. Extensional Characteristics Study of Mental Cultivation 2023-05-29

3. 幽门螺杆菌相关胃外疾病研究进展 2023-05-27

4. 社会结构行为理论及跨层次形式 2023-05-24

5. 垂体催乳素瘤的临床特点及诊治要点更新——基于《2022 版 ICCE/AME 垂体催乳素瘤临床实践共识》解读 2023-05-19

6. 阻塞性睡眠呼吸暂停患者报告结局测评工具研究现状分析 2023-05-12

7. 成年人慢性肾脏病患者感染新型冠状病毒的治疗药物选择与考虑——基于现有证据的汇总 2023-05-11

8. 脑卒中运动功能障碍患者自我管理的最佳证据总结 2023-05-08

9. 贵阳市≥18 岁抗疫一线人员对吸入用新型冠状病毒疫苗接种体验的质性研究 2023-05-08

10. 弥散张量成像联合运动诱发电位在评估脑梗死偏瘫患者运动功能预后价值的研究进展 2023-05-05

Download

Current Browse

New| Recent | 202002

Change Subject Browse

Pharmacology

Cross Subject Browse

- NO


Public comments Anonymous comments Send only to author


Public comments Anonymous comments Send only to author